179 related articles for article (PubMed ID: 26806782)
21. Use trajectories of amphetamine-type stimulants (ATS) in Shanghai, China.
Du J; Sun H; Huang D; Jiang H; Zhong N; Xu D; Zhao Y; Lin S; Wang W; Du Z; Zhao M; Hser YI
Drug Alcohol Depend; 2014 Oct; 143():44-50. PubMed ID: 25081602
[TBL] [Abstract][Full Text] [Related]
22. New insights into the mechanism of action of amphetamines.
Fleckenstein AE; Volz TJ; Riddle EL; Gibb JW; Hanson GR
Annu Rev Pharmacol Toxicol; 2007; 47():681-98. PubMed ID: 17209801
[TBL] [Abstract][Full Text] [Related]
23. Cross-border Activities Associated With Pattern of Amphetamine-type Stimulants Usage Among Drug Users in Southwest of China.
Zhang M; Li J; Fan J; Feng D; Li Q; Tang S; Li J
Inquiry; 2023; 60():469580231206608. PubMed ID: 37902428
[TBL] [Abstract][Full Text] [Related]
24. Ice in the Outback: the epidemiology of amphetamine-type stimulant-related hospital admissions and presentations to the emergency department in Hedland, Western Australia.
Monahan C; Coleman M
Australas Psychiatry; 2018 Aug; 26(4):417-421. PubMed ID: 29533079
[TBL] [Abstract][Full Text] [Related]
25. Involvement of dorsal striatal α1-containing GABAA receptors in methamphetamine-associated rewarding memories.
Jiao DL; Liu Y; Long JD; Du J; Ju YY; Zan GY; Liu JG; Zhao M
Neuroscience; 2016 Apr; 320():230-8. PubMed ID: 26868969
[TBL] [Abstract][Full Text] [Related]
26. DARK Classics in Chemical Neuroscience: Methamphetamine.
Abbruscato TJ; Trippier PC
ACS Chem Neurosci; 2018 Oct; 9(10):2373-2378. PubMed ID: 29602278
[TBL] [Abstract][Full Text] [Related]
27. Exposure to Amphetamines Leads to Development of Amphetamine Type Stimulants Associated Cardiomyopathy (ATSAC).
Jafari Giv M
Cardiovasc Toxicol; 2017 Jan; 17(1):13-24. PubMed ID: 27663745
[TBL] [Abstract][Full Text] [Related]
28. [Establishment and evaluation of animal model with methamphetamine poisoning].
Xu J; Zhou XL; Zhang H; Deng C; Zhang Y; Li Z
Fa Yi Xue Za Zhi; 2009 Aug; 25(4):282-5. PubMed ID: 19788080
[TBL] [Abstract][Full Text] [Related]
29. Epidemiological trends and the advances of treatments of amphetamine-type stimulants (ATS) in China.
Sun HQ; Chen HM; Yang FD; Lu L; Kosten TR
Am J Addict; 2014; 23(3):313-7. PubMed ID: 24724890
[TBL] [Abstract][Full Text] [Related]
30. Intravenous self-administration of amphetamine is increased in a rat model of depression.
Holmes PV; Masini CV; Primeaux SD; Garrett JL; Zellner A; Stogner KS; Duncan AA; Crystal JD
Synapse; 2002 Oct; 46(1):4-10. PubMed ID: 12211093
[TBL] [Abstract][Full Text] [Related]
31. l-Scoulerine attenuates behavioural changes induced by methamphetamine in zebrafish and mice.
Mi G; Gao Y; Yan H; Jin X; Ye E; Liu S; Gong Z; Yang H; Yang Z
Behav Brain Res; 2016 Feb; 298(Pt A):97-104. PubMed ID: 26433144
[TBL] [Abstract][Full Text] [Related]
32. [The status quo of amphetamine type stimulants use among residents aged 15-64 in a border city of Yunnan province, 2014].
Zhang CM; Luo J; Duan L; Yang GG; Li S; Wen PY; Li JH
Zhonghua Liu Xing Bing Xue Za Zhi; 2019 Apr; 40(4):446-450. PubMed ID: 31006206
[No Abstract] [Full Text] [Related]
33. The psychogenetically selected Roman rat lines differ in the susceptibility to develop amphetamine sensitization.
Corda MG; Piras G; Lecca D; Fernández-Teruel A; Driscoll P; Giorgi O
Behav Brain Res; 2005 Feb; 157(1):147-56. PubMed ID: 15617781
[TBL] [Abstract][Full Text] [Related]
34. Treatment Barriers Associated with Amphetamine-Type Stimulant (ATS) Use in Malaysia.
Singh D; Narayanan S; Shanmugam T; Vicknasingam B
J Psychoactive Drugs; 2022; 54(1):25-33. PubMed ID: 33749541
[TBL] [Abstract][Full Text] [Related]
35. Modafinil for bipolar depression with comorbid methamphetamine abuse.
Camacho A; Ng B; Frye MA
Am J Addict; 2010; 19(2):190-1. PubMed ID: 20163392
[No Abstract] [Full Text] [Related]
36. Mitochondria: key players in the neurotoxic effects of amphetamines.
Barbosa DJ; Capela JP; Feio-Azevedo R; Teixeira-Gomes A; Bastos Mde L; Carvalho F
Arch Toxicol; 2015 Oct; 89(10):1695-725. PubMed ID: 25743372
[TBL] [Abstract][Full Text] [Related]
37. [Amphetamine abuse and drug interactions].
Horwitz H; Skanning P; Askaa B; Jürgens G
Ugeskr Laeger; 2014 Nov; 176(45):. PubMed ID: 25394841
[TBL] [Abstract][Full Text] [Related]
38. Information from your family doctor. Meth abuse: what you should know.
American Academy of Family Physicians
Am Fam Physician; 2007 Oct; 76(8):1175-6. PubMed ID: 17990841
[No Abstract] [Full Text] [Related]
39. Dopamine-induced behavioral changes and oxidative stress in methamphetamine-induced neurotoxicity.
Kita T; Miyazaki I; Asanuma M; Takeshima M; Wagner GC
Int Rev Neurobiol; 2009; 88():43-64. PubMed ID: 19897074
[TBL] [Abstract][Full Text] [Related]
40. Using life course charts to assess and compare trajectories of amphetamine type stimulant consumption in different user groups: a cross-sectional study.
Martens MS; Zurhold H; Rosenkranz M; O'Donnell A; Addison M; Spencer L; McGovern W; Gabrhelík R; Petruželka B; Rowicka M; Liebregts N; Degkwitz P; Kaner E; Verthein U
Harm Reduct J; 2020 Jan; 17(1):8. PubMed ID: 31931819
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
